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ABSTRACT
The results of treatment of 250 patients with established acute
myocardial infarction in a coronary care unit in a university
hospital are described. The criteria for diagnosis have been
carefully defined. In 62 percent of patients admitted with a
tentative diagnosis of acute infarction, the initial impression
was confirmed. Fifteen percent of patients admitted to the unit
were classified as having possible infarction; in this group, the
mortality rate was 3 percent. A classification of functional
severity based on clinical evidence of heart failure or shock is
presented.
Morbidity and mortality in acute myocardial infarction are
related to the functional severity of the illness. Although
arrhythmia is common, the overriding importance of five
life-threatening arrhythmias is emphasized. Mortality of pa-
tients in the coronary care unit was not improved in comparison
to those treated under regular care until strong central direction
of therapeutic programs, immediate treatment of arrhythmia in
cardiac arrest, and delegation of some medical authority to
trained nurses was accomplished. The change in concept of the
purposes and practices of special coronary care from resuscitation
to prevention of arrhythmia is emphasized.
The mortality in myocardial infarction complicated by shock
remains high. In the absence of shock, aggressive medical
treatment in the coronary care unit reduced mortality from 26 to
7 percent. The implications of these data in the management of
patients admitted to a hospital with a diagnosis of acute
myocardial infarction are discussed.
Originally published in the American Journal of Cardiology, October 1967.
Review
In 1967, Killip and Kimball (1) published an article that
helped confirm the role of the coronary care unit (CCU) as
an important tool in the management of patients with acute
myocardial infarction (AMI). They asserted that the major
benefit of such a specialized unit is the timely recognition
and immediate treatment of life-threatening arrhythmias.
Most importantly, this landmark study established a
method for early risk stratification, or classification, of
patients admitted to CCUs with AMI, eventually desig-
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INTRODUCTION
In this edition of the Journal, we release the fourteenth in a
series of reviews of influential articles that have been previously
published in ACC journals, including the American Journal of
Cardiology (from 1958 to 1982) and JACC (from 1983 to the
present). The publication of these articles is only one aspect of the
ACC’s 50th anniversary commemoration, which highlights 50
years of leadership in cardiovascular care and education. The
articles are intended to encourage reflection on the remarkable
progress made in cardiovascular medicine over time, as well as to
acknowledge the amazing prescience of some early investigators in
anticipating and, in many cases, later guiding developments in
their field.
The working group responsible for selecting these articles and
asking reviewers to write editorials solicited suggestions from
the ACC’s clinical committees and individual members.
The group achieved consensus fairly easily, including whom the
group should ask to prepare the accompanying editorials. We
initially drew up a list of 14 general areas to cover in this series,
but later found that there are several major areas of modern
cardiology, prominently molecular cardiology, in which the truly
landmark articles have, alas, not yet been published in JACC.
Therefore, the working group decided not to categorize by subject,
but instead, to concentrate on the most important articles.
The working group, a task force of the Subcommittee for the
Commemoration of the ACC 50th Anniversary, owes a great
deal to Ms. May A. Roustom and the efficient and tireless staff
at Heart House for facilitating this project. We also wish to
thank all who suggested articles and, most important, the
authors who prepared reviews for their willingness to contribute
their time and wisdom.
Influential Articles in JACC Working Group
Sharon A. Hunt, M.D., F.A.C.C.
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nated as the the Killip classification but perhaps better
expressed as the Killip and Kimball classification or index.
The recognition of the importance of arrhythmias is
attributed to Samuel Levine (2), who in the 1920s was one
of the first physicians to outline the association between
ventricular arrhythmias and sudden death. Treatment of
sudden cardiac arrest, however, was not described until two
decades later, when several successful open chest resuscita-
tions were reported. One such resuscitation described by
Beck and colleagues (3) was of a young boy who developed
ventricular fibrillation while undergoing surgery and was
successfully cardioverted with electrical shock. In 1956,
Beck (4) reported the successful cardioversion by open
thoracotomy of a 65-year-old man with ventricular fibrilla-
tion in the setting of myocardial infarction (MI). This
advance was significant because it implied that patients with
potentially fatal MIs could be resuscitated and managed
through the crisis. Several other successful resuscitations
were reported over the following five years (5).
In 1960, several important advances laid the groundwork
for the development of the CCU. These developments
included the technique of closed chest cardiopulmonary
resuscitation and the use of the continuous telemetry mon-
itor with an alarm system allowing for prompt attention to
significant arrhythmias by hospital personnel. The first
description of the CCU was presented by Julian to the
British Thoracic Society in 1961 (6). The response was
positive, and monitoring of patients with AMI in special-
ized units began in 1962. The first CCU in the U.S. was
started by Day in Kansas, and another, not long afterward,
by Meltzer in Philadelphia.
In their landmark article, Killip and Kimball (1) described
their experience with 250 patients with AMI treated in a
specialized CCU. Patients with definite MI, as defined by
electrocardiogram findings and laboratory enzyme results of
SGOT, SGPT and LDH, were treated either on a regular
ward or in a specialized CCU. Each group was subdivided
according to severity of cardiac failure, with particular
regard for the presence or absence of cardiogenic shock. The
first analysis of mortality and morbidity data was set forth
after eight months of CCU operation. One hundred pa-
tients with definite MI treated in the CCU were compared
with 100 patients treated in a regular ward. In the initial
comparison, the mortality of the two groups was compara-
ble. However, after certain decisive policy changes in the
CCU, significant benefit was obtained. Nurses were autho-
rized to apply precordial shock if a physician was not
available within 60 s, and a clear protocol for treatment of
CCU patients was given to the in-house physician by the
senior physician. After these modifications, a significant
improvement in mortality was observed in the next 150
CCU patients who were not in cardiogenic shock. Most
notably, the mortality rate decreased from 26% for patients
treated in a regular ward to 7% for those treated in the
CCU. In addition, patients who suffered a cardiac arrest
were more likely to survive if the event occurred in the
CCU. These findings confirmed the importance of the
prompt recognition and treatment of significant arrhyth-
mias in patients with AMI.
Although the numbers were not large, for those patients
in cardiogenic shock, no benefit from intensive cardiac care
in terms of morbidity or mortality was detected. The
mortality for these patients was quite high—69% in the
patients managed on the regular floor and 85% for those
treated in the CCU. The treatment of such patients remains
a considerable therapeutic challenge today. Although there
is now evidence that the 30-day survival rate is increased in
patients with AMI complicated by cardiogenic shock who
undergo revascularization, the overall mortality remains
high. It seems likely that until further treatment options
become available for these patients, prevention of such
complications as cardiac rupture and intractable congestive
heart failure will be of fundamental concern in the manage-
ment of high-risk patients with MI.
Although Killip and Kimball (1) reported improved
mortality and morbidity in patients with AMI treated in the
CCU, the effectiveness of these units continued to be
debated over the following decades. Killip and Kimball were
not alone in reporting benefit in mortality. Others who
directly compared patients treated in the intensive care unit
with those treated in regular wards and found a benefit in
terms of mortality included Meltzer (7) and Brown and
MacMillan (8). In addition, since 1967, when the CCU
became widely instituted in the U.S., the mortality of
patients with AMI has decreased steadily in those older
than 35 and those younger than 65 years of age. This
finding, however, cannot be attributed to intensive care
alone, as many advances have occurred simultaneously,
including the primary and secondary prevention of athero-
sclerotic disease and the medical and interventional man-
agement of acute coronary syndromes. In the late 1970s,
Hill and associates (9) compared AMI patients treated at
home with those treated in the hospital. They found no
significant difference in mortality for the two groups. A
notable qualification of this study is that a significant
subgroup of patients was excluded from the trial. These
patients had a higher mortality than either of the other
groups. This finding suggests that the MI was not severe
enough in the included groups to detect a benefit from the
management in an acute CCU. In addition, this trial, as well
as other similar studies, was conducted over 20 years ago,
before vigorous techniques for controlled trials had been
established. It now seems clear that the prevention of
arrhythmic death in those patients who are at high risk is
best carried out in the CCU.
I do think, however, that there is another useful aspect of
the article by Killip and Kimball (1)—namely, the heart
failure (or severity) index they developed. This clinical index
seems to have stood the test of time. It was an attempt to
develop a bedside classification of the integrity of left
ventricular function. Obviously it is not precise, but in large
population studies it seems to work: there is a direct
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relationship between the classification and mortality. A
number of studies appear to have validated this index with
respect to mortality. There is clearly something useful in the
classification or index that Thomas Killip and John Kimball
developed.
It is possible that some of the less crude and more
accurate invasive approaches used in the CCU, such as the
routine use of the flow-directed Swan-Ganz catheter for
evaluation of ventricular function, may actually increase
mortality in some cases. The use of the Swan-Ganz catheter
in patients in intensive care units has been widely debated.
Several retrospective studies have addressed the benefit of
the Swan-Ganz catheter and have detected adverse out-
comes in some patients. No prospective clinical trials have
been undertaken to date. Some investigators have called for
a moratorium on the use of the Swan-Ganz catheter until
such a study is completed (10). It is possible, however, that
because data are often made available from the pulmonary
artery catheter, which is useful in specific clinical scenarios,
such a moratorium would not be wise (11). Generally, use of
the Swan-Ganz catheter should be limited to a small
number of absolute indications in which a specific question
is answered or by which drug therapy is guided. The most
obvious indication for cases of AMI would be in the
management of patients in cardiogenic shock who will be
treated with positive inotropic intravenous agents and di-
uretics. The length of time the catheter is left in place is also
important. A shorter duration would be less likely to lead to
such complications as bacteremia and right-sided endocar-
ditis.
This landmark article by Killip and Kimball (1) was
important in establishing the benefit of intensive care for
patients with AMI. Those patients at high risk for sudden
death are the most likely to benefit from such specialized
care. Another useful aspect of the article was the severity
index they developed. Today it is my belief that under
specific circumstances the use of an invasive monitoring
device such as the Swan-Ganz catheter is important in the
management of certain cardiac patients. However, a pro-
spective randomized controlled trial may be useful in con-
firming this benefit.
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